Hitoshi Takagi

12PUBLICATIONS
21CO-AUTHORS
Medical biochemistry - proteins and peptides (incl. medical proteomics)Social program evaluationEpidemiological modellingTraditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 15, 2026
Prognostic Value of the FIB-3 Index in Patients With Hepatic Encephalopathy Receiving Rifaximin: A Multicenter Retrospective Analysis.

|Apr 01, 2026
Long-Term Outcomes of Sofosbuvir/Velpatasvir Treatment for Hepatitis C Virus-Related Decompensated Cirrhosis: A Retrospective Multicenter Cohort Study.

Satoru Kakizaki, Tadashi Ikegami, Takeshi Hatanaka

|Jan 08, 2026
Clinical Utility of the aMAP Risk Score for Predicting the Recurrence of Hepatic Encephalopathy After Rifaximin Treatment in Patients With Liver Cirrhosis: A Retrospective Cohort Study.

Satoshi Takakusagi, Satoru Kakizaki, Yozo Yokoyama

|May 01, 2023
Endoscopic and video capsule endoscopic observation of Yersinia enterocolitis.

Kyouko Marubashi, Hitoshi Takagi, Tadatake Wakagi

|Feb 07, 2023
Two cases of hepatocellular carcinoma successfully treated by carbon ion radiotherapy after atezolizumab plus bevacizumab treatment.

Satoshi Takakusagi, Hinako Tanaka, Atsushi Naganuma

|Nov 29, 2022
Recurrence of hepatocellular carcinoma after radiofrequency ablation in a poor-risk patient with chronic renal failure and other complications successfully treated with stereotactic body radiotherapy.

Toyokazu Saito, Satoshi Takakusagi, Hitoshi Takagi

Pageof 2

Frequent Collaborators

8 joint publications

Toshio Uraoka

7 joint publications

Satoshi Takakusagi

6 joint publications

Atsushi Naganuma

5 joint publications

Takeshi Hatanaka